Skip to main navigation Skip to search Skip to main content

In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy

  • Paul A. Foster
  • , Simon P. Newman
  • , Surindaer. K. Chander
  • , Chloe Stengel
  • , Roma Jhalli
  • , Lawrence L. W. Woo
  • , Barry V. L. Potter
  • , Michael J. Reed
  • , Atul Purohit

Research output: Contribution to journalArticlepeer-review

60   Link opens in a new tab Citations (SciVal)
Original languageEnglish
Pages (from-to)5543-5549
JournalClinical Cancer Research
Volume12
Issue number18
DOIs
Publication statusPublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this